New Chief Executive for National Composites Centre
The University of Bristol announced today [Tuesday 1 May] the appointment of Rich Oldfield as the new Chief Executive of the National Composites Centre (NCC).

The University of Bristol announced today [Tuesday 1 May] the appointment of Rich Oldfield as the new Chief Executive of the National Composites Centre (NCC).

A Bristol-led team of physicists has found a way to operate mass manufacturable photonic sensors at the quantum limit. This breakthrough paves the way for practical applications such as monitoring greenhouse gases and cancer detection.

Bristol’s favourite pooch and friends will reside at three University of Bristol locations this summer as Gromit Unleashed 2 fever sweeps across the city.

The French Ambassador to the UK, Her Excellency Mme Sylvie-Agnes Bermann, visited the Hinkley Point C site in April, alongside a Franco-British delegation including Mr Vincent de Rivaz CBE, CEO of EDF Energy.

From a harp replica of the Clifton Suspension Bridge to a dress made from 4,400 lights, the University of Bristol is presenting a series of events during Digital Bristol Week which promises to entertain, inspire and enlighten.

New research has shown future wearable devices, such as smartwatches, could use ultrasound imaging to sense hand gestures.

The first computer model to simulate the whole chain of events triggered by offshore mega subduction earthquakes could reduce losses to life and property caused by disasters like the huge earthquake and tsunami that struck Japan six years ago this Saturday [11 March].

How engineering is helping track cyclists reach for gold, harnessing the power of quantum computers and the hidden world of engineering safety testing are three research projects University of Bristol academics will be showcasing at a free festival to celebrate the most exciting cutting-edge science and technology in the UK.

The University of Bristol has been chosen by global technology company Thales Group to be its first strategic partner university in the UK, in a move which will lead to new research and education opportunities.

Interim results presented here show the effectiveness of one dose of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines in preventing hospitalisation of people in their 80s with multiple comorbidities. The AvonCAP study results are reported for the first time today [3 March] by researchers from the University of Bristol, University Hospitals Bristol and Weston NHS Foundation Trust (UHBW) and North Bristol NHS Trust (NBT).